Logo-ijdrc
Review Article

1. Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer
Sepideh Izadi ORCID, Mohammad Hojjat-Farsangi, Vahid Karpisheh, Farhad Jadidi-Niaragh* ORCID
Int J Drug Res Clin. 2023;1: e2 | Published on: 2023 Mar 15. doi: 10.34172/ijdrc.2023.e2
Article
PDF
XML
Cited By:
0
CitedBy Google Scholar 1
Review Article

2. Incretin-Based Therapies and the Risk of Breast Cancer in Women with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Mobina Oladghaffari* ORCID, Sama Rahnemayan ORCID, Zahra Tohid ORCID, Majid Montazer ORCID, Farnaz Dabiri
Int J Drug Res Clin. 2023;1: e19 | Published on: 2023 Nov 29. doi: 10.34172/ijdrc.2023.e19
Article
PDF
XML
Cited By:
0
CitedBy Google Scholar 0
Original Article

3. Silencing Interleukin-6 and Glycoprotein 130 Suppresses Growth and Induces Apoptosis in Cancer Cells
Parastoo Khodayari ORCID, Atefeh Khodakarami, Hadi Hassannia, Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Vida Hashemi, Farhad Jadidi-Niaragh* ORCID
Int J Drug Res Clin. 2023;1: e8 | Published on: 2023 May 17. doi: 10.34172/ijdrc.2023.e8
Article
PDF
XML
Cited By:
0
CitedBy Google Scholar 1
Original Article

4. IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell Growth
Shiva Abolhasani ORCID, Sepideh Javadi, Hadi Hassannia, Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh* ORCID
Int J Drug Res Clin. 2023;1: e17 | Published on: 2023 Nov 07. doi: 10.34172/ijdrc.2023.e17
Article
PDF
XML
Cited By:
0
CitedBy Google Scholar 0
Original Article

5. Blockade of CD155 and Interleukin-6 Suppresses Breast Cancer Cell Growth
Atefeh Khodakarami ORCID, Samira Darvishi, Hadi Hassannia, Mohammad Sadeghi, Sana Esmaeeli, Vida Hashemi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh* ORCID
Int J Drug Res Clin. 2023;1: e10 | Published on: 2023 Jun 22. doi: 10.34172/ijdrc.2023.e10
Article
PDF
XML
Cited By:
0
CitedBy Google Scholar 1
Review Article

6. The Nephrotoxicity of Checkpoint Inhibitors: A Mini Review
Fariba Mahmoodpoor ORCID, Mohammadreza Ardalan, Aygun Nasibova, Mahbuba Valiyeva, Elham Ahmadian* ORCID
Int J Drug Res Clin. 2024;2: e1 | Published on: 2024 Feb 21. doi: 10.34172/ijdrc.2024.e1
Article
PDF
XML
Cited By:
0
CitedBy Google Scholar 0
Original Article

7. The Relationship Between Breast Cancer Risk Factors and Mammographic Density
Mahnaz Ranjkesh ORCID, Somayeh Shaker, Saba Mehrtabar, Mahya Ahmadpour Youshanlui, Samin Alihosseini* ORCID
Int J Drug Res Clin. 2024;2: e3 | Published on: 2024 Apr 03. doi: 10.34172/ijdrc.2024.e3
Article
PDF
XML
Cited By:
0
CitedBy Google Scholar 0
Original Article

8. Different Concentrations of Produced Recombinant TNF-α Protein Caused Different Cellular Viability in Breast Cancer Cell Lines
Sara Tirabadi ORCID, Mohammad Reza Nahai, Nazila Alizadeh, Mahya Ahmadpour Youshanlui, Behzad Baradaran* ORCID
Int J Drug Res Clin. 2024;2: e18 | Published on: 2024 Nov 13. doi: 10.34172/ijdrc.2024.e18
Article
PDF
XML
Cited By:
0
Original Article

9. Combined Blockade of Interleukin-6 and β-Catenin Inhibits Breast and Colon Tumor Growth In Vitro
Maryam Farajzadeh ORCID, Mohammad-Salar Hosseini, Farzaneh Eshaghi, Samira Mohebbi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh* ORCID
Int J Drug Res Clin. 2024;2: e19 | Published on: 2024 Nov 17. doi: 10.34172/ijdrc.2024.e19
Article
PDF
XML
Cited By:
0

Platinum* Open Access

*This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website. 

 

 

Following:

 

Indexing & Abstracting:

 

 

 

Supported by:

 

Society of Urological Research and Education (SURE)

 

Medical Council of the Islamic Republic of Iran, Division of Tabriz

 

 

Iranian Scientific Society of Intensive Care 

________________________

Follow Us on: